Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

PPD® Laboratories Named a Top Innovator in Drug Development

PPD
Posted on: 05 Jan 18

Pharmaceutical Product Development, LLC (PPD) today announced that PPD® Laboratories has been recognized as a 2018 top innovator in drug development by CenterWatch, a leading publisher of clinical trials information for clinical research professionals.

PPD’s Preclarus® investigator site portal and companion mobile application were acknowledged for industry leadership in the CenterWatch Monthly 25th anniversary special edition, which spotlights top innovators in clinical research.

A fully integrated component of PPD — a leading global contract research organization — PPD Laboratories offers the most comprehensive set of laboratory services in the industry, spanning bioanalytical, biomarkers, central lab, GMP and vaccine sciences.

“At PPD, innovation is embedded within everything we do because we believe it is essential to our ongoing ability to support our clients’ success,” said Christopher Fikry, M.D., executive vice president of PPD Laboratories. “As is evident with the Preclarus investigator site portal, we are focused on fostering an environment that promotes and uses innovation to provide efficiencies, advancements and differentiation that help our customers deliver life-changing therapies.”

The Preclarus investigator site portal is a web-based platform, accessible via standard web browsers, that streamlines site activities associated with clinical trials, such as subject registration, sample accessioning, test result reporting and critical value alerts.

The portal uses barcode scanning technology to register a sample immediately after an investigator site receives it from a patient. This process inserts the sample’s information directly into PPD Laboratories’ global database in real time, alerting the lab, clients and other stakeholders.

The portal’s real-time feedback has resulted in a 67 percent reduction in the number of exceptions and queries sites traditionally experience that can adversely impact the length of the drug development process.

In 2018, to further support the schedules and workflows of research professionals at investigator sites, PPD Laboratories will extend the functionality of the online Preclarus investigator site portal to a mobile application to help manage clinical trial data. Just as with the web platform, principal investigators, clinical trial managers and other clinical site staff will have the ability to view alerts, manage supplies and perform accessioning activities wherever they are by simply using mobile devices, such as smartphones or tablets.

About PPD

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 47 countries and approximately 20,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development to deliver life-changing therapies that improve health. For more information, visit www.ppdi.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180105005423/en/

Business Wire
www.businesswire.com

Last updated on: 05/01/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.